Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 months ago Source:  Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported… View more
Author(s): Tatsuya Nakama Added: 1 year ago
LINC 2025 - Outcomes from the GRIFFIN study suggest post-procedural functional flow reserve (FFR) could be a useful predictor of restenosis after drug-coated balloon (DCB) angioplasty for superficial femoral artery (SFA) lesions. Restenosis patients showed significantly lower FFR values than non-restenosis patients, and the study resulted in a good FFR cut-off value of restenosis after DCB… View more
Added: 7 months ago Source:  Radcliffe Cardiology
AUTHOR: Ola WisniewskaA novel optical coherence tomography (OCT)-based physiological assessment, virtual flow reserve (VFR), has been shown to predict 2-year clinical outcomes following percutaneous coronary intervention (PCI), independent of anatomical measures like minimal stent area (MSA). This finding comes from a new substudy of the ILUMIEN IV trial, highlighting the potential of VFR to… View more
Author(s): Robert Jay Widmer Added: 4 days ago
This expert level cath lab case features Dr Jay Robert Widmer (The McKinney Heart Hospital, US) demonstrating a complete invasive coronary reactivity testing protocol in a 25 year old woman with persistent chest pain, normal coronary CTA and non-obstructive findings.Dr Widmer walks through step-by-step assessment of coronary microvascular function using thermodilution derived CFR and IMR,… View more
Author(s): Ole De Backer , Nicolas M Van Mieghem Added: 2 months ago
PARADIGM Trial Design and Early DurAVR® THV ExperienceThis two part peer-to-peer discussion with Prof Ole De Backer (Copenhagen, DK) and Prof Nicolas van Mieghem (Rotterdam, NL) offers key insights into the evolving landscape of TAVI therapy.Part one provides a concise overview of the PARADIGM trial, a head-to-head TAVI trial comparing the biomimetic DurAVR® THV to contemporary TAVI valves in an… View more